Skip to main content
⌘K
·
Launch Terminal
Launch Terminal
Home
SEC Filings
Home
SEC Filings
Filings
Filing Date
Form Type
Company
Description
AI
Link
Learn
MCP
API
Cookie Preferences
UL · Form 144 · UNILEVER PLC | Signal8
Material events
Financial results
Capital raises
Insider transactions
Fund filings
Advanced filters
Any time
Sort
Filings
Filing Date
Form Type
Company
Description
AI
Link
Browse AI-analysed SEC filings
Page 1 of 74 · 7,390 total
MT: 6-K · ownership disclosure
MT · 6-K · 2026-10-26
UFPI: 8-K · material agreement
UFPI · 8-K · 2026-10-26
NRSN: 6-K · material agreement
NRSN · 6-K · 2026-10-26
ZTEK: 6-K · delisting
ZTEK · 6-K · 2026-10-26
NVO: 6-K · share repurchase
NVO · 6-K · 2026-10-26
TECK: 6-K · other
TECK · 6-K · 2026-10-26
GSK: 6-K · clinical trial
GSK · 6-K · 2026-10-26
GSK: 6-K · ownership disclosure
GSK · 6-K · 2026-10-26
ERIC: 6-K · share repurchase
ERIC · 6-K · 2026-10-26
FFAI: 8-K · asset sale
FFAI · 8-K · 2026-10-26
AIXC: 8-K · acquisition merger
AIXC · 8-K · 2026-10-26
PEBO: 8-K · earnings release
PEBO · 8-K · 2026-10-26
XBIT: 8-K · leadership change
XBIT · 8-K · 2026-10-26
CCEP: 6-K · share repurchase
CCEP · 6-K · 2026-10-26
AIR: 8-K · debt financing
AIR · 8-K · 2026-10-26
RACE: 6-K · share repurchase
RACE · 6-K · 2026-10-26
ACB: 6-K · litigation
ACB · 6-K · 2026-10-26
STM: 6-K · share repurchase
STM · 6-K · 2026-10-26
VICR: 10-Q · periodic report
VICR · 10-Q · 2026-10-26
SGRY: SCHEDULE 13D/A · ownership disclosure
SGRY · SCHEDULE 13D/A · 2026-10-26
PDLB: 8-K · earnings release
PDLB · 8-K · 2026-10-26
SVRE: 6-K · other
SVRE · 6-K · 2026-10-26
LUV: 424B5 · prospectus supplement
LUV · 424B5 · 2026-10-26
PRSO: 8-K · offering registration
PRSO · 8-K · 2026-10-26
SGRY: 8-K · acquisition merger
SGRY · 8-K · 2026-10-26
TXN: 424B5 · prospectus supplement
TXN · 424B5 · 2026-10-26
KOF: 6-K · earnings release
KOF · 6-K · 2026-10-26
CGEH: 8-K · leadership change
CGEH · 8-K · 2026-10-26
BSRR: 8-K · earnings release
BSRR · 8-K · 2026-10-26
NATH: 8-K · acquisition merger
NATH · 8-K · 2026-10-26
BMRC: 8-K · earnings release
BMRC · 8-K · 2026-10-26
CAAP: 6-K · debt financing
CAAP · 6-K · 2026-10-26
MBC: 8-K · leadership change
MBC · 8-K · 2026-10-26
BOH: 8-K · earnings release
BOH · 8-K · 2026-10-26
MED: 10-Q · periodic report
MED · 10-Q · 2026-10-26
SJ: 6-K · earnings release
SJ · 6-K · 2026-10-26
R: 424B3 · debt financing
R · 424B3 · 2026-10-26
BOC: 8-K · asset sale
BOC · 8-K · 2026-10-26
PG: 424B5 · prospectus supplement
PG · 424B5 · 2026-10-26
BZUN: 6-K · share repurchase
BZUN · 6-K · 2026-10-26
LVWR: 8-K · leadership change
LVWR · 8-K · 2026-10-26
CZWI: 8-K · earnings release
CZWI · 8-K · 2026-10-26
HRI: 8-K · leadership change
HRI · 8-K · 2026-10-26
PG: 424B5 · prospectus supplement
PG · 424B5 · 2026-10-26
AASP: 8-K · leadership change
AASP · 8-K · 2026-10-26
BFST: 8-K · earnings release
BFST · 8-K · 2026-10-26
PASW: 6-K · material agreement
PASW · 6-K · 2026-10-26
ITUB: 6-K · acquisition merger
ITUB · 6-K · 2026-10-26
BAK: 6-K · bankruptcy
BAK · 6-K · 2026-10-26
AURE: 6-K · auditor change
AURE · 6-K · 2026-10-26
UGP: 6-K · ownership disclosure
UGP · 6-K · 2026-10-26
MED: 8-K · earnings release
MED · 8-K · 2026-10-26
META: 424B5 · prospectus supplement
META · 424B5 · 2026-10-26
MNSO: 6-K · share repurchase
MNSO · 6-K · 2026-10-26
GAME: 8-K · acquisition merger
GAME · 8-K · 2026-10-26
MNSB: 8-K · earnings release
MNSB · 8-K · 2026-10-26
SAP: 6-K · earnings release
SAP · 6-K · 2026-10-26
RADX: 6-K · debt financing
RADX · 6-K · 2026-10-26
ARLP: 8-K · earnings release
ARLP · 8-K · 2026-10-26
OPTH: 6-K · other
OPTH · 6-K · 2026-10-26
OMH: 6-K · ticker change
OMH · 6-K · 2026-10-26
NNBR: 424B3 · prospectus supplement
NNBR · 424B3 · 2026-10-26
META: 424B5 · prospectus supplement
META · 424B5 · 2026-10-26
XNCR: 8-K · clinical trial
XNCR · 8-K · 2026-10-26
ASST: 8-K · material agreement
ASST · 8-K · 2026-10-26
ASST: 424B5 · prospectus supplement
ASST · 424B5 · 2026-10-26
UL: 6-K · leadership change
UL · 6-K · 2026-10-26
AZULQ: 6-K · debt financing
AZULQ · 6-K · 2026-10-26
SUUN: 6-K · debt financing
SUUN · 6-K · 2026-10-26
IMTX: 6-K · clinical trial
IMTX · 6-K · 2026-10-26
HDL: 6-K · material agreement
HDL · 6-K · 2026-10-26
ELBM: 6-K · other
ELBM · 6-K · 2026-10-26
BWAY: 6-K · other
BWAY · 6-K · 2026-10-26
BBVA: 6-K · share repurchase
BBVA · 6-K · 2026-10-26
ASM: 6-K · clinical trial
ASM · 6-K · 2026-10-26
FDX: 8-K · leadership change
FDX · 8-K · 2026-10-26
GCUMF: 6-K · ticker change
GCUMF · 6-K · 2026-10-26
ABOS: 8-K · earnings release
ABOS · 8-K · 2026-10-26
RRC: 8-K · acquisition merger
RRC · 8-K · 2026-10-26
CANF: 6-K · clinical trial
CANF · 6-K · 2026-10-26
VZ: 8-K · earnings release
VZ · 8-K · 2026-10-26
HBT: 8-K · earnings release
HBT · 8-K · 2026-10-26
GETY: 8-K · bankruptcy
GETY · 8-K · 2026-10-26
AZO: 8-K · leadership change
AZO · 8-K · 2026-10-26
INMD: 6-K · acquisition merger
INMD · 6-K · 2026-10-26
ZEOX: 8-K · material agreement
ZEOX · 8-K · 2026-10-26
LAWR: 6-K · delisting
LAWR · 6-K · 2026-10-26
FURY: 6-K · clinical trial
FURY · 6-K · 2026-10-26
LKFN: 8-K · earnings release
LKFN · 8-K · 2026-10-26
GSK: 6-K · clinical trial
GSK · 6-K · 2026-10-26
OVV: 8-K · acquisition merger
OVV · 8-K · 2026-10-26
HDB: 6-K · other
HDB · 6-K · 2026-10-26
BNTX: 6-K · clinical trial
BNTX · 6-K · 2026-10-26
DEA: 8-K · earnings release
DEA · 8-K · 2026-10-26
SNY: 6-K · other
SNY · 6-K · 2026-10-26
JMIA: 6-K · leadership change
JMIA · 6-K · 2026-10-26
ATMU: 8-K · leadership change
ATMU · 8-K · 2026-10-26
KKR: 8-K · leadership change
KKR · 8-K · 2026-10-26
MMYT: 6-K · earnings release
MMYT · 6-K · 2026-10-26
GSK: 6-K · clinical trial
GSK · 6-K · 2026-10-26
1
2
3
4
8
12
16
20
24
28
32
36
40
44
48
52
56
60
64
68
72
74
Next ›
